“…Since the discovery of insulin by Banting and Best in 1921, T1D became a chronic condition, but still requiring lifelong treatment. A century later, we have gained a deeper understanding of the disease and increased accessibility to anti-diabetic advancements such as insulin analogs, continuous subcutaneous insulin infusion, and continuous glucose monitoring devices.The quality of life of patients has been greatly improved, but many challenges remain ( 1 ). Whether or how these advanced technologies help improve glycemic control needs to be ensured, especially in low- and middle-income Countries.…”